You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
|
|---|---|
| Published in |
BMC Clinical Pharmacology, November 2005
|
| DOI | 10.1186/1472-6904-5-5 |
| Pubmed ID | |
| Authors |
Blas Y Betancourt, María A Marrero-Miragaya, Giset Jiménez-López, Carmen Valenzuela-Silva, Elizeth García-Iglesias, Francisco Hernández-Bernal, Francisco Debesa-García, Tania González-López, Leovaldo Alvarez-Falcón, Pedro A López-Saura, the Cuban National Network of Pharmacoepidemiology |
| Abstract |
Streptokinase (SK) is an effective fibrinolytic agent for the treatment of acute myocardial infarction (AMI). The objective of the present study was to assess the adverse drug reactions (ADRs) associated with intravenous recombinant SK in patients with AMI in routine clinical practice. |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 3% |
| Unknown | 32 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 27% |
| Student > Postgraduate | 5 | 15% |
| Student > Bachelor | 3 | 9% |
| Student > Master | 3 | 9% |
| Other | 2 | 6% |
| Other | 5 | 15% |
| Unknown | 6 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 36% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
| Agricultural and Biological Sciences | 2 | 6% |
| Economics, Econometrics and Finance | 2 | 6% |
| Nursing and Health Professions | 1 | 3% |
| Other | 5 | 15% |
| Unknown | 8 | 24% |